Dow Down 1.40% Nasdaq Down 1.59%

Incyte Corporation (INCY)

-NasdaqGS
47.91 1.14(2.32%) Oct 1, 4:00PM EDT
Prev Close:49.05
Open:49.14
Bid:46.51 x 100
Ask:48.69 x 100
1y Target Est:75.15
Beta:0.29
Earnings Date:Oct 31 - Nov 4 (Est.)
Day's Range:47.27 - 49.22
52wk Range:33.01 - 70.86
Volume:1,011,789
Avg Vol (3m):924,165
Market Cap:8.07B
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for INCY

Comparison

Symbol% ChgMkt Cap
INCYDown 2.32%8.07B
AMGN105.45B
CELG74.70B
RHHBY249.64B

Key Statistics

Forward P/E (1 yr):191.64
P/S (ttm):22.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Sep-14) :-0.02
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.43

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback